Inhalation Devices

SkyePharma offers its partners a range of leading technologies for dry powder inhalers (DPIs) and HFA-propelled (CFC-free) metered dose inhalers (MDIs) and extensive know how and experience in development of inhalation products.

Know-how and capabilities include:

Regulatory success, compliance and experience in the EU and US
Clinical, chemistry, manufacturing and controls (CMC), regulatory and programme management teams
Manufacturing capability, commercial DPI in-house and MDI, through partners
Formulation, analytical, process and device development expertise
Successful scale-up and technology transfers
Close collaborations with suppliers leading to efficient troubleshooting
Enabling formulation technology overcoming market entry barriers
Easy “off-the-shelf” equipment for processing

SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom